Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.00    -1.10 (-1.25%)
Bid:
86.00
Ask:
87.00
Spread: 1.00 (1.163%)
Market Cap: £365.71m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading update

27 Jun 2022 07:00

RNS Number : 2115Q
PZ CUSSONS PLC
27 June 2022
 

27 June 2022

 

Trading update

 

Continued strategic progress and performance in line with expectations

 

PZ Cussons plc today issues a trading update for the year ended 31 May 2022.

 

Trading in the fourth quarter has continued to be in line with expectations. As such, we anticipate reporting Group revenue for the year of approximately £590 million, with full year like for like (LFL) revenue growth of 3% and Q4 LFL growth of 7%. Growth continues to be driven primarily by improvements in price/mix, with limited impact on volumes. Our expectations for FY22 Adjusted Profit Before Tax are unchanged.

 

We continue to see good revenue momentum on our Must Win Brands, which grew 4% in Q4. This sequential improvement reflects the ongoing benefit of marketing and executional focus, a normalising of the supply challenges for US Beauty, and a significantly lower rate of decline in Carex, as the demand for the Hand Hygiene category in the UK normalises following the COVID pandemic.

 

Childs Farm, which was acquired in March, has performed in line with expectations and our plans to develop the brand are progressing well.

 

Jonathan Myers, Chief Executive Officer, said:

 

"As we close our first full financial year under our new strategy, 'Building brands for life. Today and for future generations', I am pleased with the significant progress made in returning the business to sustainable, profitable revenue growth. With a new team in place, we have re-focused on the core job of building brands and have started to unlock value through dramatically reducing complexity in our business.

 

The trading environment continues to be challenging, with high input cost inflation and pressures on household budgets. We have plans in place to mitigate the impact of this, as we continue to deliver great value for consumers, whilst also investing behind more premium innovations. The recent introduction of our new portfolio brand, Cussons Creations, for the value-conscious consumer, alongside the re-launches of Sanctuary Spa and Imperial Leather, are good examples of such initiatives. They have been well received by customers and have allowed us to secure significant distribution gains.

We have great brands and great people and, whilst there is more to be done to deliver against our strategy, we remain excited by the long-term opportunities ahead of us."

 

PZ Cussons will report FY22 results and provide a FY23 outlook, along with its Q1 trading update, on 22nd September.

 

Contact details

 

Investors

Simon Whittington - IR and Corporate Development Director

+44 (0) 7711 372 928

Media

Tim Linacre / Guy Scarborough - Instinctif

+44 (0) 20 7457 2020

 

Notes to Editors

 

Unless otherwise stated, all references to revenue growth are on a like for like ('LFL') basis which adjusts for constant currency and excludes the impact of disposals (five:am) and acquisitions (Childs Farm).

 

Figures are unaudited and are still subject to review by the Group's auditors.

 

About PZ Cussons

 

PZ Cussons is a FTSE250 listed consumer goods business, headquartered in Manchester, UK. We employ over 3,000 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Imperial Leather, Original Source, Cussons Baby, Sanctuary Spa, St.Tropez, Morning Fresh and Premier. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

 

 

Cautionary note regarding forward-looking statements

 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward looking statements contained within this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUQWQUPPPPQ
Date   Source Headline
28th Sep 20165:30 pmRNSAGM Statement
28th Sep 20167:00 amRNSAGM Trading Statement
8th Sep 20165:30 pmRNSDirector/PDMR Shareholding
1st Sep 20161:11 pmRNSDirector/PDMR Shareholding
2nd Aug 20165:30 pmRNSDirector/PDMR Shareholding
27th Jul 20165:30 pmRNSDirector/PDMR Shareholding
26th Jul 201611:05 amRNSHolding(s) in Company
26th Jul 20167:00 amRNSFinal Results
20th Jul 20165:27 pmRNSHolding(s) in Company
11th Jul 201612:18 pmRNSHolding(s) in Company
6th Jul 201612:52 pmRNSHolding(s) in Company
4th Jul 20167:00 amRNSNotice of Adoption of FRS 101
30th Jun 20165:30 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTrading Statement
6th Jun 20167:00 amRNSDirectorate Change
3rd May 20167:00 amRNSChange to the Board of Directors
28th Apr 20165:30 pmRNSDirector/PDMR Shareholding
26th Apr 20167:00 amRNSChange to the Board of Directors
14th Apr 20167:00 amRNSTrading Statement
8th Apr 20167:00 amRNSDirector/PDMR Shareholding
23rd Mar 20165:30 pmRNSDirector/PDMR Shareholding
26th Jan 20167:00 amRNSInterim Results
31st Dec 201511:42 amRNSDirector/PDMR Shareholding
15th Dec 20158:32 amRNSDirector Declaration
10th Dec 20157:00 amRNSTrading Statement
30th Sep 20155:12 pmRNSDirector/PDMR Shareholding
22nd Sep 20154:48 pmRNSResult of AGM
22nd Sep 20157:00 amRNSAGM Trading Statement
11th Aug 20155:24 pmRNSHolding(s) in Company
6th Aug 20155:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20158:18 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSFinal Results
30th Jun 20155:30 pmRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSTrading Statement
9th Apr 20157:00 amRNSTrading Update
1st Apr 20157:00 amRNSBuy-out of Glanbia Plc's stake in Nutricima JV
30th Mar 20154:44 pmRNSDirector/PDMR Shareholding
13th Feb 201510:42 amRNSDirector/PDMR Shareholding
27th Jan 20157:00 amRNSHalf Yearly Report
5th Jan 20152:27 pmRNSDirector/PDMR Shareholding
10th Dec 20147:00 amRNSTrading Update
1st Oct 20145:30 pmRNSDirector/PDMR Shareholding
24th Sep 20143:20 pmRNSDirector/PDMR Shareholding
23rd Sep 20145:30 pmRNSResult of AGM
23rd Sep 20147:00 amRNSInterim Management Statement
15th Sep 20147:00 amRNSAppointment of joint Corporate Broker
29th Aug 20145:30 pmRNSDirector/PDMR Shareholding
27th Aug 20145:30 pmRNSDirector/PDMR Shareholding
1st Aug 20147:00 amRNSAcquisition of Australian food brand five:am
29th Jul 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.